244 related articles for article (PubMed ID: 22019288)
1. A recombinant bovine herpesvirus 5 defective in thymidine kinase and glycoprotein E is immunogenic for calves and confers protection upon homologous challenge and BoHV-1 challenge.
Anziliero D; Santos CM; Brum MC; Weiblen R; Chowdhury SI; Flores EF
Vet Microbiol; 2011 Dec; 154(1-2):14-22. PubMed ID: 22019288
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
[TBL] [Abstract][Full Text] [Related]
4. A bovine herpesvirus 5 recombinant defective in the thymidine kinase (TK) gene and a double mutant lacking TK and the glycoprotein E gene are fully attenuated for rabbits.
Silva SC; Brum MC; Weiblen R; Flores EF; Chowdhury SI
Braz J Med Biol Res; 2010 Feb; 43(2):150-9. PubMed ID: 20027480
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge.
Zhang M; Fu S; Deng M; Xie Q; Xu H; Liu Z; Hu C; Chen H; Guo A
Vaccine; 2011 Nov; 29(48):8943-50. PubMed ID: 21959327
[TBL] [Abstract][Full Text] [Related]
6. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
[TBL] [Abstract][Full Text] [Related]
7. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of safety and efficacy of DNA vaccines against bovine herpesvirus-1 (BoHV-1) in calves.
Petrini S; Ramadori G; Corradi A; Borghetti P; Lombardi G; Villa R; Bottarelli E; Guercio A; Amici A; Ferrari M
Comp Immunol Microbiol Infect Dis; 2011 Jan; 34(1):3-10. PubMed ID: 19906427
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
Xue W; Ellis J; Mattick D; Smith L; Brady R; Trigo E
Vaccine; 2010 May; 28(22):3784-92. PubMed ID: 20381643
[TBL] [Abstract][Full Text] [Related]
10. Immunization and challenge experiments with a new modified live bovine herpesvirus type 1 marker vaccine prototype adjuvanted with a co-polymer.
Kalthoff D; König P; Trapp S; Beer M
Vaccine; 2010 Aug; 28(36):5871-7. PubMed ID: 20600486
[TBL] [Abstract][Full Text] [Related]
11. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
[TBL] [Abstract][Full Text] [Related]
12. Development and statistical validation of a guinea pig model for vaccine potency testing against Infectious Bovine Rhinothracheitis (IBR) virus.
Parreño V; López MV; Rodriguez D; Vena MM; Izuel M; Filippi J; Romera A; Faverin C; Bellinzoni R; Fernandez F; Marangunich L
Vaccine; 2010 Mar; 28(13):2539-49. PubMed ID: 20123054
[TBL] [Abstract][Full Text] [Related]
13. Construction and growth properties of bovine herpesvirus type 5 recombinants defective in the glycoprotein E or thymidine kinase gene or both.
Brum MC; Weiblen R; Flores EF; Chowdhury SI
Braz J Med Biol Res; 2010 Feb; 43(2):217-24. PubMed ID: 19893987
[TBL] [Abstract][Full Text] [Related]
14. Longevity of protective immunity to experimental bovine herpesvirus-1 infection following inoculation with a combination modified-live virus vaccine in beef calves.
Ellis J; Waldner C; Rhodes C; Ricketts V
J Am Vet Med Assoc; 2005 Jul; 227(1):123-8. PubMed ID: 16013547
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines.
Castrucci G; Frigeri F; Salvatori D; Ferrari M; Sardonini Q; Cassai E; Lo DM; Rotola A; Angelini R
Comp Immunol Microbiol Infect Dis; 2002 Jan; 25(1):29-41. PubMed ID: 11831745
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
[TBL] [Abstract][Full Text] [Related]
17. Modification of active immunization with live bovine herpesvirus 1 vaccine by passive viral antibody.
Patel JR; Shilleto RW
Vaccine; 2005 Jul; 23(31):4023-8. PubMed ID: 15916839
[TBL] [Abstract][Full Text] [Related]
18. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
[TBL] [Abstract][Full Text] [Related]
19. Identification of a mutant bovine herpesvirus-1 (BHV-1) in post-arrival outbreaks of IBR in feedlot calves and protection with conventional vaccination.
van Drunen Littel-van den Hurk S; Myers D; Doig PA; Karvonen B; Habermehl M; Babiuk LA; Jelinski M; Van Donkersgoed J; Schlesinger K; Rinehart C
Can J Vet Res; 2001 Apr; 65(2):81-8. PubMed ID: 11346260
[TBL] [Abstract][Full Text] [Related]
20. Immune responses in bovines to recombinant glycoprotein D of bovine herpesvirus type 5 as vaccine antigen.
Araujo IL; Dummer LA; Rodrigues PRC; Dos Santos AG; Fischer G; Cunha RC; Leite FPL
Vaccine; 2018 Nov; 36(50):7708-7714. PubMed ID: 30381153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]